Evidence map›Paper›PMID 24861182›Full record

ArticleMetabolic brain disease2014

Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in cerebral cortex of the mouse [corrected].

Raghu Vemuganti, Vinícius R Silva, Suresh L Mehta, Alan S Hazell

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Metabolic brain disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.International journal of molecular sciences · 2021
    Review
  6. Article
  7. [Research progress on the relationship between non-coding RNA and liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Raghu VemugantiDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, USA.
Vinícius R Silva
Suresh L Mehta
Alan S Hazell
Universidade Estadual de Campinas (UNICAMP) · BRUniversity of Wisconsin–Madison · US

Funding

Synergy of ER stress and oxidative stress after TBIR21NS082957 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2013 to 2014
$412k
PiRNAs and ischemic brain damageR21NS074444 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2011 to 2012
$408k
miRNAs and PPAR-gamma-induced neuroprotectionR21NS079585 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2012 to 2013
$406k
Combo therapy to curtail oxidative stress after TBIR03NS083007 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2013 to 2014
$150k
NINDS NIH HHS NS074444NINDS NIH HHS NS079585NINDS NIH HHS NS 082957NINDS NIH HHS NS083007NINDS NIH HHS R03 NS083007NINDS NIH HHS R21 NS074444NINDS NIH HHS R21 NS079585NINDS NIH HHS R21 NS082957
6 · The paper itself

Abstract

The mechanisms that promote brain dysfunction after acute liver failure (ALF) are not clearly understood. The small noncoding RNAs known as microRNAs (miRNAs) significantly control mRNA translation and thus normal and pathological functions in the mammalian body. To understand their significance in ALF, we currently profiled the expression of miRNAs in the cerebral cortex of mice sacrificed at coma stage following treatment with azoxymethane. Of the 470 miRNAs profiled using microarrays, 37 were significantly altered (20 up-and 17 down-regulated) in their expression in the ALF group compared to sham group. In silico analysis showed that the ALF-responsive miRNAs target on average 231 mRNAs/miRNA (range: 3 to 840 targets). Pathways analysis showed that many miRNAs altered after ALF target multiple mRNAs that are part of various biological and molecular pathways. Glutamatergic synapse, Wnt signaling, MAP-kinase signaling, axon guidance, PI3-kinase-AKT signaling, T-cell receptor signaling and ubiquitin-mediated proteolysis are the top pathways targeted by the ALF-sensitive miRNAs. At least 28 ALF-responsive miRNAs target each of the above pathways. We hypothesize that alterations in miRNAs and their down-stream mRNAs of signaling pathways might play a role in the induction and progression of neurological dysfunction observed during ALF.

Indexed as

Gene Expression ProfilingAnimalsAzoxymethaneCerebral CortexHepatic EncephalopathyLiver FailureMaleMetabolic Networks and PathwaysMiceMice, Inbred C57BLMicroRNAsNerve Tissue ProteinsRNA, MessengerSignal TransductionAzoxymethaneMicroRNAsNerve Tissue ProteinsRNA, Messenger

Identifiers

PMID24861182
PMCPMC8487459
OpenAlexW1995335583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.